Showing results (1461-1470 of 6,507) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational studyToshiyuki Sumi, Yutaro Nagano, Keiki Yokoo, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Understanding the impact of spatial immunophenotypes on the survival of endometrial cancer patients through the ProMisE classificationSatomi Hattori, Nobuhisa Yoshikawa, Wenting Liu, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2025
Microbial dysbiosis with tryptophan metabolites alteration in lower respiratory tract is associated with clinical responses to anti-PD-1 immunotherapy in advanced non-small cell lung cancerXiang-Xiang Chen, Qing Ju, Dan Qiu, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2025
Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancerManh-Cuong Vo, Van-Tan Nguyen, Van-Dinh-Huan Tran, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2025
ZEB1 transcription factor induces tumor cell PD-L1 expression in melanomaChloé Wirbel, Simon Durand, Félix Boivin, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2025
Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinomaChaeyeon Kim, Mina Han, Gamin Kim, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cellsZhiqi Xie, Jinjin Shao, Zeren Shen, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2025
Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphomaZheng Yijia, Xiaoyu Li, Lina Ma, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2025
Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1Hirotaka Kato, Tomohide Tsukahara, Kenji Murata, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrenceDanyang Zhou, Mei Li, Wei Wu, et al.
Pageof 651